Beth Hecht

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Grand Prairie, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Beth Hecht
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Beth Hecht

Form 4 holding Director

Iterum Therapeutics plc

Security class
Ordinary Shares
Shares / value
18,839
Estimated value
$26,375
Report date
15 Jun 2023
Price
$1.40
Ownership
Direct
Form 4 holding Chief Legal Officer and Corporate Secretary

Xeris Biopharma Holdings, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
162,162
Estimated value
Report date
30 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Iterum Therapeutics plc

Security class
Restricted Share Units
Shares / value
0
Estimated value
Report date
15 Jun 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Senior Vice President, General Counsel and Corporate Secretary

XERIS PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
05 Oct 2021
Price
Ownership
Direct
Form 4 holding Senior Vice President, General Counsel and Corporate Secretary

XERIS PHARMACEUTICALS INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Oct 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Beth Hecht

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .